Zoetis
| Zoetis, Inc.
|
|
|---|---|
 |
|
| legal form | Incorporation |
| ISIN | US98978V1035 |
| founding | 1952 |
| Seat |
Parsippany ,
|
| management | Kristin Peck ( CEO ) |
| Number of employees | 9,200 |
| sales | 5.307 billion USD |
| Branch | pharmacy |
| Website | www.zoetis.com |
| As of December 31, 2017 | |
Zoetis, Inc. is a US manufacturer of veterinary drugs and vaccines for pets and farm animals. Two thirds of sales come from the livestock sector. Measured in terms of total sales in the industry, Zoetis is currently (as of 2012) the world market leader with a share of around 20%. Founded in 1952, the company is based in Parsippany , New Jersey .
Until 2013 Zoetis was a subsidiary of the pharmaceutical company Pfizer . In early 2013, Pfizer floated its animal health business on the New York Stock Exchange , which was the largest initial public offering since Facebook . Since Pfizer sold its remaining 83% stake in June 2013, Zoetis has been independent and has been included in the S&P 500 stock market index .
In 2016 the company's headquarters were relocated from Florham Park to Parsippany-Troy Hills Township (New Jersey) .
Individual evidence
- ↑ Executive Team. In: www.zoetis.com. Retrieved February 15, 2020 .
- ↑ a b Form 10-K Report 2017 , accessed on March 10, 2018
- ↑ Zoetis share gains significantly after its stock market debut. In: Handelsblatt . February 1, 2013, accessed June 19, 2014 .
- ↑ Zoetis IPO Opens at $ 31.50 in Largest US Deal Since Facebook . In: CNBC . February 1, 2013 ( cnbc.com ).
- ↑ Pfizer says shareholders snap up remaining Zoetis shares , Reuters, June 24, 2013
- ↑ Zoetis signs 12-year lease for Parsippany office building owned by Normandy , at www.njbiz.com , accessed March 10, 2018